Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 2433334 in non-cardioembolic ischemic stroke
CTR20201235Phase 2Completed
- Sponsor
- ---
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asundexian in ischemic stroke, sponsored by ---. Started Sep 2020; status: completed.
02
Drugs
asundexian
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20201235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201235.